logo BDSP

Base documentaire

  1. Combined-modality treatment of inflammatory breast carcinoma : twenty years of experience at M. D. Anderson Cancer Center.

    Article, Communication - En anglais

    Annual Meeting of the American Society of Clinical Oncology. Los Angeles, Californie (USA), 1995/05/20.


    To review the 20 years of experience at M. D. Anderson Cancer Center with a combined-modality approach against inflammatory breast carcinoma.

    Patients and methods 

    A total of 178 patients with inflammatory breast carcinoma were treated in the past 20 years at M. D. Anderson Cancer Center by a combined-modality approach under four different protocols.

    Each protocol included induction chemotherapy, then local therapy (radiotherapy or mastectomy). then adjuvant chemotherapy, and, if mastectomy was performed, adjuvant radiotherapy.

    Chemotherapy consisted of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) with or without vincristine and prednisone (VP).

    In protocol D, patients received an alternate adjuvant chemotherapy regimen, methotrexate and vinblastine (MV), if they did not have a complete response (CR) to induction chemotherapy.

    Mots-clés Pascal : Fluorouracil, Doxorubicine, Vinblastine, Cyclophosphamide, Association médicamenteuse, Anticancéreux, Prednisone, Vincristine, Tumeur maligne, Glande mammaire, Carcinome, Inflammation, Homme, Radiothérapie, Traitement adjuvant, Traitement associé, Postopératoire, Texas, Etats Unis, Amérique du Nord, Amérique, Protocole thérapeutique, Fluoropyrimidine dérivé, Anthracyclines, Moutarde à l'azote, Oxazaphosphinane dérivé, Corticostéroïde, Alcaloïde, Vinca, Apocynaceae, Dicotyledones, Angiospermae, Spermatophyta, Chirurgie, Glande mammaire pathologie, Rétrospective, Epidémiologie

    Mots-clés Pascal anglais : Fluorouracil, Doxorubicin, Vinblastine, Cyclophosphamide, Drug combination, Antineoplastic agent, Prednisone, Vincristine, Malignant tumor, Mammary gland, Carcinoma, Inflammation, Human, Radiotherapy, Adjuvant treatment, Combined treatment, Postoperative, Texas, United States, North America, America, Therapeutic protocol, Fluoropyrimidine derivatives, Anthracyclins, Nitrogen mustard, Oxazaphosphinane derivatives, Corticosteroid, Alkaloid, Vinca, Apocynaceae, Dicotyledones, Angiospermae, Spermatophyta, Surgery, Mammary gland diseases, Retrospective, Epidemiology

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0398540

    Code Inist : 002B02R04. Création : 12/09/1997.